Thrivent Financial for Lutherans cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 11.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,401 shares of the company’s stock after selling 7,926 shares during the quarter. Thrivent Financial for Lutherans’ holdings in GE HealthCare Technologies were worth $5,282,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of the stock. Western Wealth Management LLC lifted its position in GE HealthCare Technologies by 2.4% in the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after buying an additional 125 shares during the last quarter. United Community Bank lifted its position in GE HealthCare Technologies by 10.2% in the fourth quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after buying an additional 130 shares during the last quarter. Thoma Capital Management LLC lifted its position in GE HealthCare Technologies by 1.4% in the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after buying an additional 136 shares during the last quarter. Colonial Trust Advisors increased its stake in GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares during the period. Finally, Norinchukin Bank The increased its stake in GE HealthCare Technologies by 0.4% in the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after purchasing an additional 149 shares during the period. 82.06% of the stock is currently owned by institutional investors.
Insider Activity
In other news, Director Watkin Phoebe L. Yang purchased 1,000 shares of the business’s stock in a transaction dated Friday, May 8th. The shares were purchased at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the purchase, the director owned 13,702 shares in the company, valued at approximately $863,363.02. This represents a 7.87% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO James Saccaro purchased 3,310 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were purchased at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the purchase, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have bought 11,847 shares of company stock valued at $719,555. Company insiders own 0.36% of the company’s stock.
GE HealthCare Technologies Stock Performance
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research firms have weighed in on GEHC. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and reduced their target price for the stock from $75.00 to $69.00 in a research note on Thursday. BNP Paribas Exane reduced their target price on GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Evercore set a $80.00 target price on GE HealthCare Technologies in a research note on Thursday, April 30th. Argus reduced their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday. Finally, JPMorgan Chase & Co. reduced their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $80.21.
Check Out Our Latest Stock Report on GEHC
GE HealthCare Technologies Company Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
